Catalyst Pharmaceuticals Inc (STU:CN2)
€ 27.5 (0%) Market Cap: 3.38 Bil Enterprise Value: 2.72 Bil PE Ratio: 18.10 PB Ratio: 3.80 GF Score: 70/100

Catalyst Pharmaceuticals Inc (STU:CN2) Transcripts

  • 1